TDP-43

Pan He1, Yuanyuan Li2, Xinyu Zhou3

  • 1Department of Neurology, Third Affiliated Hospital of Zunyi Medical University (The First People's Hospital of Zunyi), Zunyi 563000, China; Chinese Pharmacological Society-Guizhou Province Joint Laboratory for Pharmacology, Zunyi, Guizhou, China; Department of Geriatrics, Third Affiliated Hospital of Zunyi Medical University (The First People's Hospital of Zunyi), Zunyi, Guizhou, China; National Drug Clinical Trial Institution, Third Affiliated Hospital of Zunyi Medical University (The First People's Hospital of Zunyi), Zunyi, Guizhou, China.

Brain research
|July 5, 2025
PubMed
概括

野生型和突变型TDP-43都通过降低progranulin (PGRN) 和Caspase-3来损害认知功能和神经元健康. 这项研究提供了有关TDP-43的神经退行性疾病的见解.

相关概念视频